Bibliografías temáticas / Inflammatory bowel diseas / Artículos de revistas
Siga este enlace para ver otros tipos de publicaciones sobre el tema: Inflammatory bowel diseas.

Artículos de revistas sobre el tema "Inflammatory bowel diseas"

Autor: Grafiati
Publicado: 1 de febrero de 2025

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Inflammatory bowel diseas".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

KASKI, M. CARPANI y H. J. F. HODGSON. "Rolling review: inflammatory bowel diseas". Alimentary Pharmacology & Therapeutics 7, n.º 5 (31 de marzo de 2007): 567–79. http://dx.doi.org/10.1111/j.1365-2036.1993.tb00134.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

O’Sullivan, Maria y Colm O’Morain. "Nutritional therapy in inflammatory bowel diseas". Current Treatment Options in Gastroenterology 7, n.º 3 (junio de 2004): 191–98. http://dx.doi.org/10.1007/s11938-004-0040-2.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Mancho, Carolina, Ángel Sainz, Mercedes García-Sancho, Alejandra Villaescusa, Miguel A. Tesouro y Fernando Rodríguez-Franco. "Detection of Perinuclear Antineutrophil Cytoplasmic Antibodies and Antinuclear Antibodies in the Diagnosis of Canine Inflammatory Bowel Diseas". Journal of Veterinary Diagnostic Investigation 22, n.º 4 (julio de 2010): 553–58. http://dx.doi.org/10.1177/104063871002200409.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Theocharidou, Eleni, Melachrini Mavroudi, Konstantinos Soufleris, Alexandros Mpoumponaris, Andreas Nakos, Theodora Griva, Nikolaos Grammatikos, Eleni Mavroudi, Geleris Paraschos y Nicolaos Evgenidis. "T1333 Increased Pulse Wave Velocity in Patients With Inflammatory Bowel Diseas. Preliminary Results of an Ongoing Study". Gastroenterology 138, n.º 5 (mayo de 2010): S—539. http://dx.doi.org/10.1016/s0016-5085(10)62486-9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Alexander, Richard J., Asit Panja, Evonne Kaplan-Liss, Lloyd Mayer y Robert F. Raicht. "Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel diseas". Digestive Diseases and Sciences 40, n.º 3 (marzo de 1995): 485–94. http://dx.doi.org/10.1007/bf02064355.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Eindor, A., L. Meleady y K. Jacobson. "P147 Progression to biologic treatment in very early onset inflammatory bowel disease patients- a long term follow up retrospective study". Journal of Crohn's and Colitis 15, Supplement_1 (1 de mayo de 2021): S229—S230. http://dx.doi.org/10.1093/ecco-jcc/jjab076.274.

Texto completo
Resumen
Abstract Background Very early onset inflammatory bowel disease (VEOIBD) prevalence has been increasing over the last decades. These young patients have been known to have special disease characteristics and disease location. Although it is known that only a low percentage of these patients require biologic treatment after diagnosis, there is only scarce evidence about their long- term outcome and biologic requirements. We aimed to assess the long term outcome of VEOIBD patients and the time of progression to biologic treatment. Methods We retrospectively reviewed IBD patients diagnosed under 6 years of age, between January 2005 and December 2019, from the British Columbia (BC) Pediatric IBD database. Demographic data, disease characteristics and symptoms at diagnosis were documented. The disease location and severity were documented according to the Paris classification. Data collected retrospectively until the last appointment recorded in the electronic medical records included whether the patient received biologic treatment at the time of follow up, the time to intiation of the treatment, the type of biologic treatment and response. Kaplan meier curves were used to asses the number of years to progression to biologic treatment and the parameters influencing it. Results 89 patients under the age of 6 were diagnosed with IBD during the study period. 3 patients failed to meet inclusion criteria and were excluded. Median age at diagnosis was 3.8 (IQR 2.6–5.1). 45.3% of patients had Crohn’s disease (CD) and 62.8% were males. Median time of follow up was 6.39 (IQR 3.71–10.55). 68.1% of the ulcerative colitis (UC) patients had pancolitis and 48.7% of CD patients had ileocolonic disease. 39.5% of patients were started on biologic treatment and 7.1% underwent surgery. Kaplan Meier curves demonstrated that patients diagnosed in the years 2012 -2019 had shorter duration of progression to biologics than those diagnosed 2005–2011 (p=0.0047). In patients with CD those with perianal or stricturing disease progressed faster to biologic treatment (p=0.024,p=0.038, respectively) and in UC patients those with high severity of disease (p=0.017). 63.6% of patients were reported to be on clinical remission on the biologic treatment. Conclusion Although VEOIBD patients have more extensive diseas, they require less biologic treatment than previously reported in older patients. Factors influencing shorter duration of progression to biologics were the severity of disease and behaviour and not disease location. Patients diagnosed more recently had shorter duration to biologic treatment which might reflect physicians perception on using biologic treatment in these young patients rather than disease severity.
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Falcón-Guerrero, Britto Ebert. "Coincidencia entre la periodontitis y la enfermedad inflamatoria del intestino". Kiru 20, n.º 1 (31 de marzo de 2023): 28–33. http://dx.doi.org/10.24265/kiru.2023.v20n1.03.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

HUSNÍK, R., J. KLIMEŠ, K. TOMANOVÁ, J. SMOLA, R. HALOUZKA, F. TICHÝ y J. BRÁZDIL. "Lawsonia intracellularis in a dog with inflammatory bowel disease". Veterinární Medicína 48, No. 5 (30 de marzo de 2012): 141–45. http://dx.doi.org/10.17221/5761-vetmed.

Texto completo
Resumen
A two-year-old male German short-haired pointer was presented with a 1.5-year history of intermittent small-bowel diarrhoea. Inflammatory bowel disease (chronic lymphocytic-plasmacytic gastritis, enteritis and colitis) was diagnosed on the basis of histological examination of biopsies obtained on repeated endoscopy and by exclusion of other possible causes. Warthin-Starry silver staining of stomach mucosa revealed the presence of gastric spiral organisms. The evidence of L. intracellularis was provided by a positive nested polymerase chain reaction in one biopsy of duodenal mucosa and in one rectal smear. In 5 blood sera collected over a period of 8 months the IgG antibodies to L. intracellularis were found by an indirect fluorescent antibody test. Treatment with oral prednisone led only to a temporary improvement.
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Fernandes, Isabel y Lúcia Gil. "Qualidade de vida da pessoa com doença inflamatória intestinal". Revista de Enfermagem Referência IV Série, n.º 23 (23 de diciembre de 2019): 89–98. http://dx.doi.org/10.12707/riv19048.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Kumar Kasula Suresh, Bharath. "Emerging Therapies for Inflammatory Bowel Disease: A Systematic Overview". International Journal of Science and Research (IJSR) 13, n.º 3 (5 de marzo de 2024): 1449–51. http://dx.doi.org/10.21275/mr24322201434.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
11

Kumar, Puneet, Sunita Devi, Pramod Kumar, Nisha Devi y Shivali Singla. "A Review on Inflammatory Bowel Disease: Diagnosis and Treatment". International Journal of Science and Research (IJSR) 11, n.º 4 (5 de abril de 2022): 412–14. http://dx.doi.org/10.21275/sr22406110623.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
12

S, Hajare. "A Demographic Profile of Inflammatory Bowel Disease in Uttar Karnataka". Gastroenterology & Hepatology International Journal 4, n.º 2 (22 de julio de 2019): 1–7. http://dx.doi.org/10.23880/ghij-16000165.

Texto completo
Resumen
Inflammatory bowel disease (IBD) results from production of dysregulated gut mucosal immune response to luminal antigens. Scientific literature pertaining to Southern part of Indian is limited, especially with focus on demographic and clinical phenotypes of IBD. Hence, the present study is aimed at evaluating these factors in a geographic area of Uttar Karnataka in two types of IBD- Ulcerative colitis (UC) and Crohn’s disease (CD). Methodology: A retrospective study was done with 91 patients with IBD from 2009 to 2019. Patients were routinely started on treatment with local and systemic 5-aminosalicylic acid derivatives. Different line of therapies was administered to both UC and Crohn’s disease with different drugs or combination of drugs. Results: Of the 91 patients, 85 were having UC and 6 with CD. The mean age of patients with UC and CD was 41.8 years and 52.2 years; male predominance was observed in UC group of patients in contrast to CD group. UC patients were found with Extraintestinal manifestation i.e. Erythema nodosum (0.01%), Type 1 peripheral arthritis (0.01%), Type 2 peripheral arthritis (0.01%). A total of 6 UC patients required surgery for various causes, with the majority being males, including 2 of them who developed cancer. Conclusion: There was a predominance of patients with UC, especially in men. The age, origin and level of education may interfere with early diagnosis. This geographical region survey provides an opportunity for understanding possible etiopathogenetic factors associated with the disease and pattern of treatment.
Los estilos APA, Harvard, Vancouver, ISO, etc.
13

Bustelo, Dolores y Tatiana Fazecas. "A importância da ultrassonografia com Doppler na doença inflamatória intestinal em pediatria". Radiologia Brasileira 56, n.º 5 (septiembre de 2023): IX—X. http://dx.doi.org/10.1590/0100-3984.2023.56.5e3.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
14

Dudanova, Olga Petrovna, Nadezhda Alekseevna Larina, Lidija Valerievna Prokapovich y Anastasia Andreevna Larina. "Steatohepatitis in patients with inflammatory bowel diseases in Karelia". Journal of Biomedical Technologies, n.º 1 (junio de 2014): 10–17. http://dx.doi.org/10.15393/j6.art.2014.2981.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
15

Garg, Praveen Kumar, Taruna Choudhary y Bharat Gomtiwall. "To Study of Spectrum of Inflammatory Bowel Disease in Western Rajasthan". Asian Journal of Medical Research 8, n.º 2 (junio de 2019): ME15—ME17. http://dx.doi.org/10.21276/ajmr.2019.8.2.me6.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
16

Kastуukevich, L. I., O. N. Romanova, N. D. Kolomiets, K. Y. Marakhovsky, O. V. Krasko, O. N. Nazarenko y O. L. Savich. "СРАВНИТЕЛЬНАЯ ХАРАКТЕРИСТИКА РАЗНЫХ ТИПОВ ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЙ КИШЕЧНИКА У ДЕТЕЙ". Hepatology and Gastroenterology 7, n.º 2 (diciembre de 2023): 127–34. http://dx.doi.org/10.25298/2616-5546-2023-7-2-127-134.

Texto completo
Resumen
Background. Inflammatory bowel disease (IBD) is a group of idiopathic, chronic, relapsing inflammatory conditions of the gastrointestinal tract including ulcerative colitis (UC), Crohn's disease (CD), and unspecified colitis (UnC). Objective. To provide a comparative characteristic of clinical and laboratory features of various IBD types in children according to the morphology, and to identify clinical and laboratory markers of unspecified colitis in children. Material and methods. 118 pediatric patients diagnosed with chronic inflammatory bowel disease were observed. Statistical processing of clinical and laboratory data was carried out using the statistical package R, version 4.1. Results. A comprehensive examination revealed 36 patients with Crohn's disease (CD), 54 those with ulcerative colitis (UC), and 28 with UnC. It was found out that in patients diagnosed with unspecified colitis, clinical manifestations were statistically more often observed at an earlier age (28,5 months [8; 50]) in contrast to children with UC (31 months [14; 122]) and CD patients (96 months [34,5;132]) (p=0,004). All patients with IBD had significant changes in stool frequency (from 3 to 9 or more times per day), 45 (83.3%) patients with UC having blood in stool (p <0.001). Pain syndrome was less common in patients diagnosed with UnC – 22 (78,6%) (p=0,048). The two clinical and laboratory symptoms were significantly more often observed in the group of patients with UC: protein-energy malnutrition (PEM) – 24 (44,4%)(p=0.008) and anemia – 39 (72,2%) (p<0.001). Patients diagnosed with UnC had a lower platelet count (292±68) (p=0.005). CD patients had a lower mean relative lymphocyte count (30,8%) (p=0.005). The level of C-reactive protein (CRP) was significantly more often elevated in patients with UC – 30 (55,6%) (p=0,005). Conclusions. Though standard methods used for examining patients with IBD allow us to establish the diagnoses of UC and CD, such examination is not sufficient for children with UnC. It is necessary to include new molecular genetic criteria in the examination protocol for patients with IBD, which will make it possible to offer appropriate treatment at an early stage of the disease.
Los estilos APA, Harvard, Vancouver, ISO, etc.
17

K Tyagi, C., Anju Balkrishna Bhandole y Harish N Kakrani. "Evaluation of Herbal Plants Used in Treatment of Inflammatory Bowel Disease". International Journal of Science and Research (IJSR) 11, n.º 12 (5 de diciembre de 2022): 950–57. http://dx.doi.org/10.21275/sr221212152611.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
18

Banakar, Ranjeeta S. y Rangaswamy R. "Spectrum of Histopathology of Inflammatory Bowel Disease in A Teaching Hospital, Bangalore". Indian Journal of Pathology: Research and Practice 7, n.º 2 (2018): 207–11. http://dx.doi.org/10.21088/ijprp.2278.148x.7218.13.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
19

Mounika, Gai, Vuppunuthala Ramkamladhar, Ch Praneeth Kumar y K. Ravinder Reddy. "Unveiling Strongyloidiasis: A Mimicker of Inflammatory Bowel Disease with Unique Clinical Presentation". International Journal of Science and Research (IJSR) 12, n.º 9 (5 de septiembre de 2023): 646–47. http://dx.doi.org/10.21275/sr23905105335.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
20

Beal, Eliza W., Rosara Bass y Alan E. Harzman. "Two Patients with FulminantClostridium difficileEnteritis Who Had Not Undergone Total Colectomy: A Case Series and Review of the Literature". Case Reports in Surgery 2015 (2015): 1–5. http://dx.doi.org/10.1155/2015/957257.

Texto completo
Resumen
Introduction.Clostridium difficileis the most common cause of healthcare associated infectious diarrhea, and its most common clinical manifestation is pseudomembranous colitis. Small bowel enteritis is reported infrequently in the literature and typically occurs only in patients who have undergone ileal pouch anastomosis due to inflammatory bowel disease or total abdominal colectomy for other reasons.Presentation of Cases. We report here two cases in which patients developed small bowelC. difficileenteritis in the absence of these underlying conditions.Discussion. Neither patient had underlying inflammatory bowel disease and both had a significant amount of colon remaining.Conclusion. These two cases demonstrate that small bowelC. difficileenteritis should be included in the differential diagnosis of patients on antibiotic therapy who demonstrate signs and symptoms of worsening abdominal disease during their postoperative course, even if they lack the major predisposing factors of inflammatory bowel disease or history of total colectomy.
Los estilos APA, Harvard, Vancouver, ISO, etc.
21

Ahmed Majeed, Hiba. "Detection of Cytomegalovirus in Patients with Inflammatory Bowel Diseases in Iraq". Journal of Communicable Diseases 55, n.º 03 (7 de diciembre de 2023): 67–74. http://dx.doi.org/10.24321/0019.5138.202341.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
22

Patel, Parth, Richa Sharma y Yatish x. "Association of Self Medication with Analgesics and Smoking among Inflammatory Bowel Disease Patients". International Journal of Science and Research (IJSR) 11, n.º 9 (5 de septiembre de 2022): 860–61. http://dx.doi.org/10.21275/mr22916223327.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
23

Sewell, Justin L. y Uma Mahadevan. "Of Blemishes and Bowels: Isotretinoin and Inflammatory Bowel Disease". Gastroenterology 138, n.º 1 (enero de 2010): 392–94. http://dx.doi.org/10.1053/j.gastro.2009.11.029.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
24

Hyams, J. S. "Inflammatory Bowel Disease". Pediatrics in Review 26, n.º 9 (1 de septiembre de 2005): 314–20. http://dx.doi.org/10.1542/pir.26-9-314.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
25

Glick, S. R. y R. S. Carvalho. "Inflammatory Bowel Disease". Pediatrics in Review 32, n.º 1 (31 de diciembre de 2010): 14–25. http://dx.doi.org/10.1542/pir.32-1-14.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
26

Shapiro, J. M., S. Subedi y N. S. LeLeiko. "Inflammatory Bowel Disease". Pediatrics in Review 37, n.º 8 (1 de agosto de 2016): 337–47. http://dx.doi.org/10.1542/pir.2015-0110.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
27

Hyams, J. S. "Inflammatory Bowel Disease". Pediatrics in Review 21, n.º 9 (1 de septiembre de 2000): 291–95. http://dx.doi.org/10.1542/pir.21-9-291.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
28

Moses, Peter L., Brad R. Moore, Nicholas Ferrentino, Steven P. Bensen y James A. Vecchio. "Inflammatory bowel disease". Postgraduate Medicine 103, n.º 5 (mayo de 1998): 77–102. http://dx.doi.org/10.3810/pgm.1998.05.483.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
29

Glick, Sarah R. y Ryan S. Carvalho. "Inflammatory Bowel Disease". Pediatrics In Review 32, n.º 1 (1 de enero de 2011): 14–25. http://dx.doi.org/10.1542/pir.32.1.14.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
30

Hyams, Jeffrey S. "Inflammatory Bowel Disease". Pediatrics In Review 21, n.º 9 (1 de septiembre de 2000): 291–95. http://dx.doi.org/10.1542/pir.21.9.291.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
31

Hyams, Jeffrey S. "Inflammatory Bowel Disease". Pediatrics In Review 26, n.º 9 (1 de septiembre de 2005): 314–20. http://dx.doi.org/10.1542/pir.26.9.314.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
32

Moll, J. M. H. "Inflammatory Bowel Disease". Clinics in Rheumatic Diseases 11, n.º 1 (abril de 1985): 87–111. http://dx.doi.org/10.1016/s0307-742x(21)00590-7.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
33

MAYBERRY, J. F. "Inflammatory Bowel Disease". Gut 49, n.º 2 (1 de agosto de 2001): 314.3–314. http://dx.doi.org/10.1136/gut.49.2.314-b.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
34

Vatn, Morten H. y Arne K. Sandvik. "Inflammatory bowel disease". Scandinavian Journal of Gastroenterology 50, n.º 6 (8 de abril de 2015): 748–62. http://dx.doi.org/10.3109/00365521.2015.1033000.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
35

Podolsky, Daniel K. "Inflammatory Bowel Disease". New England Journal of Medicine 347, n.º 6 (8 de agosto de 2002): 417–29. http://dx.doi.org/10.1056/nejmra020831.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
36

Abraham, Clara y Judy H. Cho. "Inflammatory Bowel Disease". New England Journal of Medicine 361, n.º 21 (19 de noviembre de 2009): 2066–78. http://dx.doi.org/10.1056/nejmra0804647.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
37

Schuman, Bernard M. "Inflammatory bowel disease". Postgraduate Medicine 83, n.º 4 (marzo de 1988): 291–94. http://dx.doi.org/10.1080/00325481.1988.11700202.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
38

Floch, Martin H. "Inflammatory Bowel Disease". Journal of Clinical Gastroenterology 45, n.º 9 (octubre de 2011): 839. http://dx.doi.org/10.1097/mcg.0b013e31822be119.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
39

Hanauer, Stephen B. y Daan W. Hommes. "Inflammatory bowel disease". Expert Review of Clinical Immunology 6, n.º 4 (julio de 2010): 499–500. http://dx.doi.org/10.1586/eci.10.52.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
40

McClenathan, Daniel T. "Inflammatory Bowel Disease". Journal of Pediatric Gastroenterology and Nutrition 10, n.º 2 (febrero de 1990): 277. http://dx.doi.org/10.1097/00005176-199002000-00032.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
41

Schölmerich, J. "Inflammatory Bowel Disease". Endoscopy 28, n.º 01 (enero de 1996): 77–82. http://dx.doi.org/10.1055/s-2007-1005421.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
42

Ottenjann, R. "Inflammatory Bowel Disease". Endoscopy 26, n.º 01 (enero de 1994): 64–69. http://dx.doi.org/10.1055/s-2007-1005812.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
43

Zakaria, Alan A. y Sami F. Rifat. "Inflammatory Bowel Disease". Current Sports Medicine Reports 7, n.º 2 (marzo de 2008): 104–7. http://dx.doi.org/10.1097/01.csmr.0000313398.94816.47.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
44

Ambrose, N. S. "Inflammatory bowel disease". Current Opinion in Gastroenterology 2, n.º 3 (mayo de 1986): 377–78. http://dx.doi.org/10.1097/00001574-198605000-00010.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
45

Rhodes, J. M. "Inflammatory bowel disease". Current Opinion in Gastroenterology 2, n.º 3 (mayo de 1986): 405–9. http://dx.doi.org/10.1097/00001574-198605000-00014.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
46

&NA;. "Inflammatory bowel disease". Current Opinion in Gastroenterology 2, n.º 3 (mayo de 1986): 449–56. http://dx.doi.org/10.1097/00001574-198605000-00018.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
47

Ambrose, N. S. "Inflammatory bowel disease". Current Opinion in Gastroenterology 3, n.º 3 (mayo de 1987): 423. http://dx.doi.org/10.1097/00001574-198705000-00009.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
48

Rhodes, J. M. "Inflammatory bowel disease". Current Opinion in Gastroenterology 3, n.º 3 (mayo de 1987): 438–43. http://dx.doi.org/10.1097/00001574-198705000-00012.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
49

Ambrose, N. S. "Inflammatory bowel disease". Current Opinion in Gastroenterology 3, n.º 3 (mayo de 1987): 460–64. http://dx.doi.org/10.1097/00001574-198705000-00015.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
50

&NA;. "Inflammatory bowel disease". Current Opinion in Gastroenterology 3, n.º 3 (mayo de 1987): 523–32. http://dx.doi.org/10.1097/00001574-198705000-00017.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
También puede estar interesado en las bibliografías sobre el tema "Inflammatory bowel diseas" para otros tipos de fuentes:
Tesis Libros
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía